Pirfenidone

Esbriet Coupons & Discount Card – Guaranteed Prices from $323.66

pirfenidone

Pirfenidone, marketed as Esbriet, is an antifibrotic medication prescribed for adults with idiopathic pulmonary fibrosis (IPF), a condition that causes scarring and stiffness in the lungs, making breathing difficult. This medication aims to decelerate the progression of IPF by presumably reducing lung inflammation and scarring. It is administered orally three times a day with food, beginning at a low dose that is gradually increased. Common side effects may include nausea, stomach pain, and skin rash. Regular liver function tests are recommended due to potential liver-related side effects. Pirfenidone is available in both brand-name and generic forms.
Our Esbriet coupons are free to use. You can print the coupon, email it to yourself, or receive the Esbriet coupon via text message. To get your free discount, show the pharmacist your Esbriet savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Esbriet prices will update based on your prescription needs. Above our Esbriet coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Esbriet savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

267MG, Pirfenidone (30 Capsules)

Select pharmacy

Pharmacy logo

Walgreens

$323.66

COUPON PRICE
Pharmacy logo

Rite Aid

$877.79

COUPON PRICE

Esbriet savings card

Show this card to your pharmacist
Pharmacy logo

Walgreens

$323.66

BIN

ID

PCN

GRP

019876

LHB3CA80EB

CHIPPO

LHX

Powered by

This card is not insurance

More prescriptions for idiopathic pulmonary fibrosis

coupons from$6814.02Save 72%

More prescriptions for idiopathic pulmonary fibrosis

Ofev Save 72%coupons from $6814.02

Esbriet dosage forms

The average cost for 30 Capsules of Esbriet (pirfenidone) at 267MG is $323.66 with a free coupon. This is 74% off the average retail price of $1252.5
DosageQuantityPrice fromPer unit
267MG30 Capsules$323.66$10.79

Esbriet Warnings

Below are important safety warnings and precautions for the use of Pirfenidone (Esbriet). Please review these details carefully and consult your healthcare provider with any questions or concerns:

  • Liver Injury: Pirfenidone (Esbriet) has the potential to cause significant liver issues, which can be severe or even life-threatening. Your healthcare provider will conduct liver enzyme tests prior to starting treatment, followed by monthly tests for the first six months, and then every three months thereafter, or as deemed necessary. If you experience symptoms such as severe nausea, vomiting, pain in the upper right abdomen, fatigue, loss of appetite, or yellowing of the skin or eyes, seek medical attention immediately as these may indicate liver problems. Liver enzyme levels typically normalize upon discontinuation or dose adjustment of the medication.

  • Sunlight Sensitivity: This medication increases the sensitivity of your skin to sunlight and ultraviolet light, making sunburns more likely. This sensitivity can occur even in winter or on cloudy days. To minimize risks, apply sunscreen with an SPF of 50 or higher when outdoors and wear protective clothing. It is advisable to limit sun exposure and avoid tanning lamps, especially if you are taking other medications that increase sun sensitivity.

  • Severe Skin Reactions: Although rare, serious skin reactions like Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or drug reaction with eosinophilia and systemic symptoms (DRESS) have been reported. If you notice skin changes such as rash, blisters, redness, peeling, or if you experience fever and swollen lymph nodes, discontinue use immediately and seek medical help. If diagnosed with one of these conditions, you will need to stop taking Pirfenidone (Esbriet) permanently.

  • Stomach-related Side Effects: Commonly, Pirfenidone (Esbriet) may cause gastrointestinal issues such as nausea, stomach pain, diarrhea, and indigestion, particularly during the first three months of treatment. These side effects usually resolve over time. If they persist, consult your healthcare provider.

There are no contraindications available for this medication. Always communicate with your healthcare provider regarding any pre-existing conditions or current medications to ensure safe use of Pirfenidone (Esbriet).

Esbriet Side Effects

When taking this medication, some common side effects may occur, such as nausea, rash, stomach pain or discomfort, upper respiratory tract infections, diarrhea, tiredness, headache, reduced appetite, indigestion, dizziness, and vomiting. These effects are generally mild and often subside over time. However, if they persist or worsen, it is advisable to consult a healthcare provider.

Other reported side effects include heartburn, sinus inflammation, sleep difficulties, weight loss, joint pain, general weakness, skin sensitivity, itchiness, changes in taste, and non-heart-related chest pain. While these are less common, they should still be monitored, and if they become concerning, seek medical advice.

In rare instances, serious side effects may occur, requiring immediate medical attention. These include signs of liver damage, such as persistent nausea or vomiting, loss of appetite, abdominal pain, yellowing of the eyes or skin, and dark urine. Additionally, severe skin reactions like hives, blisters, skin reddening or peeling, and mouth sores should be urgently addressed. It is crucial to be aware of these potential side effects to ensure timely management and care.

Esbriet Interactions

Certain medications can impact the elimination of pirfenidone from your system, potentially altering its effectiveness. These include rifamycins, like rifampin, and seizure medications, such as phenytoin. Additionally, smoking cigarettes lowers the concentration of pirfenidone in your blood. It's important to inform your healthcare provider if you smoke or have recently quit smoking.
Esbriet FAQs
What is the success rate of Esbriet?

The success rate of Esbriet (pirfenidone) can vary depending on the individual and the progression of idiopathic pulmonary fibrosis (IPF). Clinical trials have shown that Esbriet can slow the decline in lung function and reduce disease progression in some patients with IPF. However, the response to treatment can differ among individuals, and not all patients may experience the same level of benefit. It is important for patients to discuss their specific case and treatment expectations with their healthcare provider.

Esbriet (pirfenidone) is used to treat idiopathic pulmonary fibrosis (IPF), a condition that causes scarring of the lungs. It helps slow down the progression of the disease by reducing lung fibrosis and inflammation, thereby preserving lung function and improving the patient's quality of life.

The cost of Esbriet (pirfenidone) can vary significantly based on factors such as insurance coverage, location, and pharmacy. Without insurance, the annual cost can be quite high, often exceeding tens of thousands of dollars. Patients are encouraged to check with their insurance provider for specific coverage details and to explore any available patient assistance programs that may help reduce the cost.

Ofev (nintedanib) and Esbriet (pirfenidone) are both medications used to treat idiopathic pulmonary fibrosis (IPF), a condition characterized by progressive scarring of the lungs. The primary difference between the two lies in their mechanisms of action. Ofev is a tyrosine kinase inhibitor that targets multiple pathways involved in fibrosis, while Esbriet works by reducing the production of collagen and other substances that contribute to fibrosis. Both medications aim to slow the progression of the disease, but they may have different side effect profiles and dosing regimens. A healthcare provider can help determine which medication is more suitable for a specific patient based on their individual health needs and response to treatment.

It is generally not recommended to take Ofev (nintedanib) and Esbriet (pirfenidone) together. Both medications are used to treat idiopathic pulmonary fibrosis (IPF) and have similar effects on the body, which could increase the risk of side effects. A healthcare provider should be consulted to determine the most appropriate treatment plan for an individual's specific condition.

Related Drugs